Free Communication Orals #1: Technology & New Treatments for Type 2 Diabetes

Tracks
Breakout 3: Central B&C
Wednesday, August 20, 2025
11:00 AM - 1:00 PM
Central Room B&C

Speaker

Dr David Oneal
Endocrinologist
St Vincent's Hospital

Impact of re-cellularization via electroporation therapy on Continuous Glucose Monitoring (CGM) metrics in Type 2 diabetes: Insights from the REGENT-1 trial

11:00 AM - 11:15 AM

Abstract

Biography

Dr John Apostolopoulos is a research fellow with the Diabetes Technology Research Group based at the University of Melbourne.
Agenda Item Image
Dr Ted Wu
Senior Specialist Endocrinologist And Director Of The Diabetes Centre
Royal Prince Alfred Hospital

Weight reduction with tirzepatide use by baseline HbA1c category in adults with overweight or obesity and type 2 diabetes in SURMOUNT-2

11:15 AM - 11:30 AM

Abstract

Biography

Dr Ted Wu is a senior specialist endocrinologist and the Director of the Diabetes Centre at The Royal Prince Alfred Hospital in Sydney, Australia - an International Diabetes Federation “Centre of Education” and National Association of Diabetes Centres “Centre of Excellence. He is also an Honorary Professor at the Shijiazhuang Diabetes Hospital in Hebei, China.
Prof Elif Ekinci
Head Of Department, Medicine Melbourne Medical School
University of Melbourne

Pulsed electric field induced duodenal re-cellularization impact on insulin sensitivity and beta cell function: Results from REGENT-1, an open-label, prospective study in Type 2 diabetes

11:30 AM - 11:45 AM

Abstract

Biography

Professor Elif Ekinci is a clinician scientist and an academic endocrinologist working to translate research into improved outcomes for people with type 1 and type 2 diabetes. Her research is focused on the pathophysiology, prevention, detection and treatment of diabetes and its complications in humans.
Dr David Oneal
Endocrinologist
St Vincent's Hospital

Effects of energy dosing on efficacy and safety in an open-label study of endoscopic pulsed electric field induced electroporation in type 2 Diabetes (REGENT-1 trial)

11:45 AM - 12:00 PM

Abstract

Biography

David O'Neal is a clinical researcher with an interest in diabetes technology and metabolic control. He has appointments with the University of Melbourne, St Vincent's Hospital Melbourne and the Baker Institute
Agenda Item Image
Prof Richard MacIsaac
Physician
Epworth Richmond

Association of tirzepatide with kidney parameters in people with obesity and prediabetes from SURMOUNT-1 over 176 weeks

12:00 PM - 12:15 PM

Abstract

Biography

Richard MacIsaac is a clinician-researcher who is currently Professor and Director of Endocrinology and Diabetes at St Vincent’s Hospital Melbourne and the University of Melbourne, Victoria, Australia. He is also the diabetes kidney disease co-stream leader for the Australian Centre for Accelerating Diabetes Innovations (ACADI), University of Melbourne.
Assoc Prof Samantha Hocking
Associate Professor Diabetes Australia
University of Sydney

Change in body composition with tirzepatide in adults with early-onset obesity in SURMOUNT-1

12:15 PM - 12:30 PM

Abstract

Biography

Associate Professor Samantha Hocking is an Endocrinologist at Royal Prince Alfred Hospital and a Clinical Academic at the University of Sydney. She is a member of the Australian and New Zealand Obesity Society (ANZOS) Council and the current president of the National Association of Clinical Obesity Services (NACOS).
Dr Sophie Poulter
Endocrinologist
Queensland Health

Limited weight regain from nadir weight in SURMOUNT-1 3-year study

12:30 PM - 12:45 PM

Abstract

Biography

Dr. Sophie Poulter is Director of Obstetric Medicine, Senior Endocrinologist at Sunshine Coast University Hospital and senior lecturer at Griffith University. Her research focus is technology use for diabetes in pregnancy. She is a recent ex-chair of the QCDN Diabetes in Pregnancy group and has coauthored multiple statewide guidelines.
Assoc Prof Samantha Hocking
Associate Professor Diabetes Australia
University of Sydney

Reduction in cardiovascular events with icosapent ethyl in patients with diabetes and prior CABG: REDUCE-IT Diabetes-Prior CABG

12:45 PM - 1:00 PM

Abstract

Biography

Associate Professor Samantha Hocking is an Endocrinologist at Royal Prince Alfred Hospital and a Clinical Academic at the University of Sydney. She is a member of the Australian and New Zealand Obesity Society (ANZOS) Council and the current president of the National Association of Clinical Obesity Services (NACOS). A/Prof Hocking’s research interests are focused on the metabolic complications of obesity. She is passionate about education to improve the quality of obesity care in Australia. In addition, she treats patients at the Metabolism and Obesity Service, Royal Prince Alfred Hospital.
Prof Elif Ekinci
Head Of Department, Medicine Melbourne Medical School
University of Melbourne

Chairperson

Biography

Assoc Prof Tongzhi Wu
Associate Professor
The University of Adelaide

Chairperson

Biography

loading